Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 09:30PM GMT
Release Date Price: $14.37 (-1.30%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

All right. Welcome, everyone. Let's go ahead and get started. This is the fireside chat with Certara. My name is Vikram Purohit. I'm one of the biotech analysts with the Morgan Stanley Research team. I need to read a brief disclosure statement. For important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

With that, I'm very happy to have with me the team from Certara. Thank you both for joining us. Really appreciate it. So we have roughly 25 minutes and a good amount of material to cover, but Bill, maybe I'll turn it to you first, just for some opening remarks just to kind of level set us on some of the key milestones you feel like Certara has hit throughout the year, some of the key inflection points for the business overall, both on the software side and on the services side, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot